301239 普瑞眼科
已收盘 11-10 15:00:00
资讯
新帖
简况
普瑞眼科(301239)11月9日主力资金净卖出425.79万元
证券之星 · 11-10 10:22
普瑞眼科(301239)11月9日主力资金净卖出425.79万元
研报掘金|平安证券:维持普瑞眼科“推荐”评级,公司经营业绩持续向好
格隆汇 · 11-06
研报掘金|平安证券:维持普瑞眼科“推荐”评级,公司经营业绩持续向好
普瑞眼科(301239)11月4日主力资金净卖出539.98万元
证券之星 · 11-05
普瑞眼科(301239)11月4日主力资金净卖出539.98万元
普瑞眼科(301239)10月30日主力资金净卖出181.00万元
证券之星 · 11-02
普瑞眼科(301239)10月30日主力资金净卖出181.00万元
普瑞眼科(301239)2026年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 10-31
普瑞眼科(301239)2026年三季报简析:营收净利润同比双双增长,盈利能力上升
普瑞眼科(301239)10月28日主力资金净买入721.55万元
证券之星 · 10-29
普瑞眼科(301239)10月28日主力资金净买入721.55万元
普瑞眼科(301239)9月30日股东户数1.15万户,较上期增加9.57%
证券之星 · 10-28
普瑞眼科(301239)9月30日股东户数1.15万户,较上期增加9.57%
10月28日普瑞眼科跌5.46%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-28
10月28日普瑞眼科跌5.46%,融通健康产业灵活配置混合A/B基金重仓该股
普瑞眼科(301239)10月27日主力资金净卖出152.41万元
证券之星 · 10-28
普瑞眼科(301239)10月27日主力资金净卖出152.41万元
普瑞眼科(301239.SZ)发布前三季度业绩,归母净利润1.51亿元,同比增长823.97%
智通财经网 · 10-28
普瑞眼科(301239.SZ)发布前三季度业绩,归母净利润1.51亿元,同比增长823.97%
普瑞眼科(301239)10月26日主力资金净买入511.28万元
证券之星 · 10-27
普瑞眼科(301239)10月26日主力资金净买入511.28万元
10月26日普瑞眼科涨5.64%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-26
10月26日普瑞眼科涨5.64%,融通健康产业灵活配置混合A/B基金重仓该股
股市必读:普瑞眼科(301239)10月22日董秘有最新回复
证券之星 · 10-23
股市必读:普瑞眼科(301239)10月22日董秘有最新回复
普瑞眼科(301239)10月20日主力资金净卖出281.94万元
证券之星 · 10-21
普瑞眼科(301239)10月20日主力资金净卖出281.94万元
10月19日普瑞眼科涨8.00%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-19
10月19日普瑞眼科涨8.00%,融通健康产业灵活配置混合A/B基金重仓该股
普瑞眼科(301239)10月16日主力资金净卖出50.28万元
证券之星 · 10-19
普瑞眼科(301239)10月16日主力资金净卖出50.28万元
普瑞眼科(301239)10月15日主力资金净买入1247.32万元
证券之星 · 10-16
普瑞眼科(301239)10月15日主力资金净买入1247.32万元
普瑞眼科(301239)9月28日主力资金净卖出337.96万元
证券之星 · 09-29
普瑞眼科(301239)9月28日主力资金净卖出337.96万元
普瑞眼科(301239)披露关于注销部分募集资金专项账户的公告,9月23日股价下跌1.12%
证券之星 · 09-23
普瑞眼科(301239)披露关于注销部分募集资金专项账户的公告,9月23日股价下跌1.12%
普瑞眼科(301239)2026年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-30
普瑞眼科(301239)2026年中报简析:营收净利润同比双双增长,盈利能力上升
加载更多
公司概况
公司名称:
普瑞眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-07-05
主营业务:
普瑞眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。公司的主要产品是屈光项目、白内障项目、医学视光项目和综合眼病项目,包含了屈光手术、医学验光配镜、白内障、青光眼、斜弱视与小儿眼病、眼底病、眼整形及泪道、角膜病等眼科全科诊疗项目。
发行价格:
33.65
{"stockData":{"symbol":"301239","market":"SZ","secType":"STK","nameCN":"普瑞眼科","latestPrice":35.09,"timestamp":1794294192000,"preClose":34.86,"halted":0,"volume":1604428,"delay":0,"changeRate":0.0066,"floatShares":142000000,"shares":150000000,"eps":0.4932,"marketStatus":"已收盘","change":0.23,"latestTime":"11-10 15:00:00","open":35,"high":35.24,"low":34.78,"amount":56212400,"amplitude":0.0132,"askPrice":35.11,"askSize":7,"bidPrice":35.09,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.4932,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":5,"adr":0,"adjPreClose":34.86,"symbolType":"stock","openAndCloseTimeList":[[1794274200000,1794281400000],[1794286800000,1794294000000]],"highLimit":38.35,"lowLimit":31.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":149619048,"isCdr":false,"pbRate":2.43,"roa":"--","peRate":71.147607,"roe":"7.15%","epsLYR":-0.41,"committee":0.025478,"marketValue":5250000000,"turnoverRate":0.0113,"status":0,"floatMarketCap":4984000000},"requestUrl":"/m/hq/s/301239","defaultTab":"news","newsList":[{"id":"2682359233","title":"普瑞眼科(301239)11月9日主力资金净卖出425.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682359233","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682359233?lang=zh_cn&edition=full","pubTime":"2026-11-10 10:22","pubTimestamp":1794277373,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月9日收盘,普瑞眼科报收于34.86元,下跌3.19%,换手率1.92%,成交量2.73万手,成交额9642.65万元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入823.59万元,融资偿还638.72万元,融资净买入184.87万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000011565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681083722","title":"研报掘金|平安证券:维持普瑞眼科“推荐”评级,公司经营业绩持续向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2681083722","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681083722?lang=zh_cn&edition=full","pubTime":"2026-11-06 15:18","pubTimestamp":1793949518,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301239","BK0236","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681982018","title":"普瑞眼科(301239)11月4日主力资金净卖出539.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681982018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681982018?lang=zh_cn&edition=full","pubTime":"2026-11-05 09:34","pubTimestamp":1793842472,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月4日收盘,普瑞眼科报收于35.3元,下跌0.9%,换手率2.72%,成交量3.87万手,成交额1.37亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入1372.59万元,融资偿还1026.99万元,融资净买入345.6万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500011079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680786148","title":"普瑞眼科(301239)10月30日主力资金净卖出181.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786148?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:08","pubTimestamp":1793581709,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月30日收盘,普瑞眼科报收于35.0元,上涨1.71%,换手率3.15%,成交量4.48万手,成交额1.57亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入983.1万元,融资偿还727.61万元,融资净买入255.48万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679601242","title":"普瑞眼科(301239)2026年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679601242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679601242?lang=zh_cn&edition=full","pubTime":"2026-10-31 03:13","pubTimestamp":1793387596,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期普瑞眼科发布2026年三季报。截至本报告期末,公司营业总收入24.46亿元,同比上升11.15%,归母净利润1.51亿元,同比上升823.97%。按单季度数据看,第三季度营业总收入8.44亿元,同比上升13.84%,第三季度归母净利润6295.21万元,同比上升3643.42%。本报告期普瑞眼科盈利能力上升,毛利率同比增幅6.67%,净利率同比增幅561.88%。本文数据来源于普瑞眼科2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100004817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679415754","title":"普瑞眼科(301239)10月28日主力资金净买入721.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679415754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679415754?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:14","pubTimestamp":1793236485,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月28日收盘,普瑞眼科报收于34.66元,下跌5.46%,换手率5.49%,成交量7.8万手,成交额2.71亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入1718.68万元,融资偿还1336.33万元,融资净买入382.36万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900016035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678469854","title":"普瑞眼科(301239)9月30日股东户数1.15万户,较上期增加9.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678469854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678469854?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:55","pubTimestamp":1793184903,"startTime":"0","endTime":"0","summary":"证券之星消息,近日普瑞眼科披露,截至2026年9月30日公司股东户数为1.15万户,较6月30日增加1001.0户,增幅为9.57%。在医疗服务行业个股中,普瑞眼科股东户数低于行业平均水平,截至9月30日,医疗服务行业平均股东户数为4.96万户。从股价来看,2026年6月30日至2026年9月30日,普瑞眼科区间涨幅为6.02%,在此期间股东户数增加1001.0户,增幅为9.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800041593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678632454","title":"10月28日普瑞眼科跌5.46%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678632454","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678632454?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:55","pubTimestamp":1793177737,"startTime":"0","endTime":"0","summary":"证券之星消息,10月28日普瑞眼科跌5.46%,收盘报34.66元,换手率5.49%,成交量7.8万手,成交额2.71亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共14家,其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800036934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678608438","title":"普瑞眼科(301239)10月27日主力资金净卖出152.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678608438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678608438?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:08","pubTimestamp":1793149705,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,普瑞眼科报收于36.66元,上涨0.83%,换手率3.15%,成交量4.48万手,成交额1.63亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入662.33万元,融资偿还824.91万元,融资净偿还162.58万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678104340","title":"普瑞眼科(301239.SZ)发布前三季度业绩,归母净利润1.51亿元,同比增长823.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678104340","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678104340?lang=zh_cn&edition=full","pubTime":"2026-10-28 00:36","pubTimestamp":1793118970,"startTime":"0","endTime":"0","summary":"普瑞眼科(301239.SZ)发布2026年第三季度报告,公司前三季度实现营业收入24.46亿元,同比增长11.15%;归属于上市公司股东的净利润1.51亿元,同比增长823.97%;归属于上市公司股东的扣除非经常性损益的净利润1.59亿元,同比增长543.98%;基本每股收益1.01元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astockgonggao/agugonggao10.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astockgonggao/agugonggao10.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678143659","title":"普瑞眼科(301239)10月26日主力资金净买入511.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678143659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678143659?lang=zh_cn&edition=full","pubTime":"2026-10-27 09:03","pubTimestamp":1793063035,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月26日收盘,普瑞眼科报收于36.36元,上涨5.64%,换手率3.67%,成交量5.21万手,成交额1.88亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入861.08万元,融资偿还961.66万元,融资净偿还100.58万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700011257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678631041","title":"10月26日普瑞眼科涨5.64%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678631041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678631041?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:45","pubTimestamp":1793004310,"startTime":"0","endTime":"0","summary":"证券之星消息,10月26日普瑞眼科涨5.64%,收盘报36.36元,换手率3.67%,成交量5.21万手,成交额1.88亿元。重仓普瑞眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600022148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677028993","title":"股市必读:普瑞眼科(301239)10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677028993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677028993?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:12","pubTimestamp":1792696333,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,普瑞眼科报收于34.0元,下跌1.42%,换手率2.1%,成交量2.99万手,成交额1.01亿元。董秘最新回复投资者: 尊敬的董秘你好,请问截止到2026-10-21号为止股东人数是多少,谢谢!根据信息披露的公平性原则,公司将按照证券监管的相关规定,在定期报告中面向所有投资者统一披露截至报告期末的股东户数。当日关注点交易信息汇总:10月22日主力资金净流入425.29万元,占总成交额4.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300002593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677439806","title":"普瑞眼科(301239)10月20日主力资金净卖出281.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677439806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677439806?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:16","pubTimestamp":1792545397,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月20日收盘,普瑞眼科报收于34.93元,下跌1.96%,换手率3.27%,成交量4.64万手,成交额1.62亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入944.67万元,融资偿还673.09万元,融资净买入271.58万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100008393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509134","title":"10月19日普瑞眼科涨8.00%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509134?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:36","pubTimestamp":1792398991,"startTime":"0","endTime":"0","summary":"证券之星消息,10月19日普瑞眼科涨8.00%,收盘报35.63元,换手率4.54%,成交量6.45万手,成交额2.23亿元。重仓普瑞眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676579788","title":"普瑞眼科(301239)10月16日主力资金净卖出50.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676579788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676579788?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:08","pubTimestamp":1792372098,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,普瑞眼科报收于32.99元,上涨3.68%,换手率3.29%,成交量4.68万手,成交额1.53亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入593.95万元,融资偿还958.06万元,融资净偿还364.12万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551435","title":"普瑞眼科(301239)10月15日主力资金净买入1247.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675551435?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:03","pubTimestamp":1792112602,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月15日收盘,普瑞眼科报收于31.82元,上涨3.04%,换手率3.62%,成交量5.14万手,成交额1.66亿元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入749.61万元,融资偿还726.13万元,融资净买入23.47万元,连续3日净买入累计136.95万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261835","title":"普瑞眼科(301239)9月28日主力资金净卖出337.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671261835?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:09","pubTimestamp":1790644172,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,普瑞眼科报收于31.72元,上涨0.7%,换手率1.59%,成交量2.26万手,成交额7189.37万元。近5日资金流向一览见下表:普瑞眼科融资融券信息显示,融资方面,当日融资买入489.74万元,融资偿还508.38万元,融资净偿还18.64万元。普瑞眼科主营业务:主要从事各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669802102","title":"普瑞眼科(301239)披露关于注销部分募集资金专项账户的公告,9月23日股价下跌1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669802102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669802102?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:38","pubTimestamp":1790156336,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘,普瑞眼科报收于31.65元,较前一交易日下跌1.12%,最新总市值为47.35亿元。该股当日开盘31.98元,最高32.06元,最低31.6元,成交额达5070.34万元,换手率为1.12%。近日,普瑞眼科医院集团股份有限公司发布《关于注销部分募集资金专项账户的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300030672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663704872","title":"普瑞眼科(301239)2026年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663704872","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663704872?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:33","pubTimestamp":1788042823,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期普瑞眼科发布2026年中报。截至本报告期末,公司营业总收入16.02亿元,同比上升9.78%,归母净利润8810.88万元,同比上升500.71%。按单季度数据看,第二季度营业总收入7.82亿元,同比上升9.02%,第二季度归母净利润1746.35万元,同比上升238.47%。本报告期普瑞眼科盈利能力上升,毛利率同比增幅5.26%,净利率同比增幅372.24%。本文数据来源于普瑞眼科2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794329636570,"stockEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.12},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.1876},{"period":"1year","weight":-0.0855},{"period":"ytd","weight":0.0769}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":-0.0393},{"period":"3month","weight":-0.0717},{"period":"6month","weight":-0.1231},{"period":"1year","weight":-0.0883},{"period":"ytd","weight":-0.0769}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"普瑞眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"11464人(较上一季度增加9.57%)","perCapita":"12390股","listingDate":"2022-07-05","address":"四川省成都市金牛区一环路北四段215号","registeredCapital":"14961万元","survey":" 普瑞眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗服务与医学验光配镜,致力于为全年龄段人群提供“全年龄段、全程视力、全视觉场景”的眼科全科医疗与眼健康管理服务。公司的主要产品是屈光项目、白内障项目、医学视光项目和综合眼病项目,包含了屈光手术、医学验光配镜、白内障、青光眼、斜弱视与小儿眼病、眼底病、眼整形及泪道、角膜病等眼科全科诊疗项目。","listedPrice":33.65},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普瑞眼科(301239)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普瑞眼科(301239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普瑞眼科,301239,普瑞眼科股票,普瑞眼科股票老虎,普瑞眼科股票老虎国际,普瑞眼科行情,普瑞眼科股票行情,普瑞眼科股价,普瑞眼科股市,普瑞眼科股票价格,普瑞眼科股票交易,普瑞眼科股票购买,普瑞眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普瑞眼科(301239)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普瑞眼科(301239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}